on 01 Oct 2019
Last Applicant/ Owned by
15 Corporate Place South
Piscataway
NJ
08854
Serial Number
88232534 filed on 17th Dec 2018
Registration Number
5871682 registered on 01st Oct 2019
Correspondent Address
TIMOTHY X. GIBSON
Filing Basis
1. use application currently
Disclaimer
NO DATA
Providing medical information in the field of pharmacovigilance and clinical trials FOUR C Training services in the field of pharmacovigilance and regulatory compliance The mark consists of the characters "4" and "C" are adjacent one another, and four crescents of diminishing size when viewed from left to right are positioned with the open sides of the crescents at varying degrees about the chaRead More
Providing medical information in the field of pharmacovigilance and clinical trials
08th Sep 2018
08th Sep 2018
Technical writing for others; technical writing in the field of medical writing; searching and retrieving information, sites, and other resources available on computer networks for others; consulting services for others in the field of design, planning, and implementation project management of clinical trials and pharmacovigilance; installation and maintenance of pharmacovigilance computer software; tracking and monitoring of safety and/or efficacy for drugs, devices, drug/device combinations, biologics, biosimilars, cosmetics, nutraceuticals or consumer products for others for pharmacovigilance purposes
08th Sep 2018
08th Sep 2018
Regulatory submission management, namely, assisting others in preparing and filing applications for new drugs, generic drugs, medical devices, drug/device combinations, biologics, biosimilars, nutraceuticals, consumer products or cosmetics with governmental regulatory bodies; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for new drug, generic drug, medical device, drug/device combination, biologic, biosimilar, nutraceutical, consumer product or cosmetic approval; regulatory submission management, namely, assisting others in preparing and filing applications for new drugs, generic drugs, medical devices, drug/device combinations, biologics, biosimilars, nutraceuticals, consumer products or cosmetics with governmental regulatory bodies; providing consulting services in the field of regulatory submission management to companies to assist them with applications for new drug, generic drug, medical device, drug/device combination, biologic, biosimilar, nutraceutical, consumer product or cosmetic approval Interactive record-keeping services for use in risk management and regulatory compliance by insurers and professionals in the medical field; business risk assessment services
08th Sep 2018
08th Sep 2018
Regulatory compliance consulting in the field of prescription drug sampling; tracking and monitoring regulatory requirements in the field of new drugs, generic drugs, medical devices, drug/device combinations, biologics, biosimilars, nutraceuticals, consumer products or cosmetics for regulatory compliance purposes; regulatory compliance consulting in the field of new drugs, generic drugs, medical devices, drug/device combinations, biologics, biosimilars, nutraceuticals, consumer products or cosmetics
08th Sep 2018
08th Sep 2018
Training services in the field of pharmacovigilance and regulatory compliance
08th Sep 2018
08th Sep 2018
No 88232534
No Service Mark
No 984-004
No
No
No
No
No
No
No
No
01.11.02 -
Partial moons, including half moons and crescent moons
26.17.09 -
Curved line(s), band(s) or bar(s)
The mark consists of the characters "4" and "C" are adjacent one another, and four crescents of diminishing size when viewed from left to right are positioned with the open sides of the crescents at varying degrees about the character "4".
| Status Date | Action Taken |
|---|---|
| 01st Oct 2019 | REGISTERED-PRINCIPAL REGISTER |
| 16th Jul 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 16th Jul 2019 | PUBLISHED FOR OPPOSITION |
| 26th Jun 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 13th Jun 2019 | ASSIGNED TO LIE |
| 30th May 2019 | EXAMINER'S AMENDMENT ENTERED |
| 30th May 2019 | EXAMINERS AMENDMENT E-MAILED |
| 30th May 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 30th May 2019 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 30th May 2019 | EXAMINERS AMENDMENT -WRITTEN |
